Featured Product
This Week in Quality Digest Live
Health Care Features
Jon Speer
As a medical device manufacturer, you can expect to be inspected
Taran March @ Quality Digest
Life science and tech companies bump heads to interpret the new map
Dirk Dusharme @ Quality Digest
Huge amounts of biometric, DNA, and diagnostic data enable personalized medicine. They also enable unscrupulous and discriminatory marketing.
Zach Y. Brown
Price transparency tools with useful, easy-to-use information can benefit patients and reduce healthcare costs
Stephen McCarthy
For quality, the future is still much bigger than the past

More Features

Health Care News
Certification bodies can conduct food safety audits and issue certifications of foreign food facilities
Creates adaptive system for managing product development and post-market quality for devices with software elements
Transforming a dysfunctional industry
An invite from Alcon Laboratories
Intended to harmonize domestic and international requirements
The FDA wants medical device manufactures to succeed, new technologies in supply chain managment
Neuroscientists train a deep neural network to analyze speech and music
Pharma quality teams will have performance-oriented objectives as well as regulatory compliance goals

More News

marcus evans

Health Care

Implement an Efficient Pharmaceutical Quality Risk Management System

Sept. 28–30, 2016, in Berlin

Published: Wednesday, August 17, 2016 - 13:58

(marcus evans: London) -- Pharmaceutical quality systems have shifted in recent years from a traditional model to a more global, dynamic, and risk-based approach, enhanced especially by regulatory authorities and economic environment. marcus evans is organizing the conference, “Quality Risk Management & Process Validation in the Product Life Cycle,” which will be held Sept. 28–30, 2016, in Berlin.

This conference will help attendees to implement a quality risk management approach into their existing quality systems. It will also provide a better understanding of how to assess and evaluate risks in their companies and with third-party partners.

By attending this conference, attendees will be able to be part of more than 14 hours of focused, end-user-driven case studies, interactive panel discussions, and workshops. In addition, delegates will have the opportunity to network with senior-level executives and learn about the latest developments and trends in pharmaceutical quality systems.

The key topic areas are:
• Effectively integrate ICH Q8, Q9, Q10, and Q11 guidelines into the quality system
• Discuss regulatory expectation on process validation
• Define an efficient quality risk management system and tools across the global quality system
• Design efficient processes to ensure quality control
• Correctly handle third-party partners within quality risk management processes
• Apply efficient continuous process verification to monitor the system

Read the interview with conference guest speaker Michael Schousboe, principal specialist, quality risk management at Novo Nordisk.

For more information about this event, contact Yiota Andreou at yiotaa@marcusevanscy.com and visit the event website here.

Discuss

About The Author

marcus evans’s picture

marcus evans

marcus evans is one of the world’s leading providers and promoters of global summits, strategic conferences, professional training, in-company training, business-to-business congresses, sports hospitality, and on-line information.